Himmelreich Jeffrey C 4
4 · MAIA Biotechnology, Inc. · Filed Apr 30, 2024
Insider Transaction Report
Form 4
Himmelreich Jeffrey C
Head of Finance
Transactions
- Award
Stock Options
2024-04-26+10,000→ 10,000 totalExercise: $2.94Exp: 2034-04-26→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The stock options, granted on April 26, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversay of the date of the grant and the remaining options to vest ratably monthly thereafter for 36 months.